Literature DB >> 15822818

Comparative status of activated ERK1/2 and PARP cleavage in human gliomas.

Vasanth Kumar Bhaskara1, Manas Panigrahi, Sundaram Challa, Phanithi Prakash Babu.   

Abstract

Gliomas are the most common form of cerebral tumors. Understanding molecular features of glioma will eventually allow for targeted intervention and more promising approaches for treating gliomas. The present study is therefore carried out to check the levels of activated ERK1/2 with respect to phospho-tyrosine and cleavage of poly ADP-ribose polymerase (PARP). Recent experiments support that extracellular signal regulated kinase (ERK), a mitogen activated protein (MAP) kinase might have a critical role in cell proliferation. PARP is a DNA-repair enzyme activated by DNA strand breaks. Overactivation of PARP after cellular insult lead to cell death caused by rapid depletion of cellular ATP. Three glioblastoma multiforme (GBM) and two astrocytoma biopsies (core tumor) and peripheral tissues were analyzed for the expression of p-ERK1/2 and PARP. Results indicate higher p-ERK1/2 in GBM. Cleaved fragments of PARP (89 kDa) were found to be more in core tumor tissue samples as compared to peripheral tumor tissues of both astrocytoma and GBM.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15822818     DOI: 10.1111/j.1440-1789.2004.00585.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  9 in total

1.  Transferrin receptor 2 is frequently and highly expressed in glioblastomas.

Authors:  Alessia Calzolari; Luigi Maria Larocca; Silvia Deaglio; Veronica Finisguerra; Alessandra Boe; Carla Raggi; Lucia Ricci-Vitani; Francesco Pierconti; Fabio Malavasi; Ruggero De Maria; Ugo Testa; Roberto Pallini
Journal:  Transl Oncol       Date:  2010-04       Impact factor: 4.243

2.  PTPIP51 levels in glioblastoma cells depend on inhibition of the EGF-receptor.

Authors:  M K Petri; A Brobeil; J Planz; A Bräuninger; S Gattenlöhner; U Nestler; A Stenzinger; A Paradowska; M Wimmer
Journal:  J Neurooncol       Date:  2015-04-11       Impact factor: 4.130

3.  Expressions of matrix metalloproteinase-7 and matrix metalloproteinase-14 associated with the activation of extracellular signal-regulated kinase1/2 in human brain gliomas of different pathological grades.

Authors:  Hui Xie; Yi-xue Xue; Li-bo Liu; Ping Wang; Yun-hui Liu; Hao-qiang Ying
Journal:  Med Oncol       Date:  2010-08-31       Impact factor: 3.064

4.  Racial and tissue-specific cancer risk associated with PARP1 (ADPRT) Val762Ala polymorphism: a meta-analysis.

Authors:  Noel Pabalan; Ofelia Francisco-Pabalan; Hamdi Jarjanazi; Hong Li; Lillian Sung; Hilmi Ozcelik
Journal:  Mol Biol Rep       Date:  2012-10-17       Impact factor: 2.316

5.  Biochemical and apoptotic changes in the nervous and ovotestis tissues of Biomphalaria alexandrina following infection with Schistosoma mansoni.

Authors:  Mohamed R Habib; Samah I Ghoname; Rasha E Ali; Rasha M Gad El-Karim; Alaa A Youssef; Roger P Croll; Mark W Miller
Journal:  Exp Parasitol       Date:  2020-03-26       Impact factor: 2.011

6.  pERK, pAkt and pBad: a possible role in cell proliferation and sustained cellular survival during tumorigenesis and tumor progression in ENU induced transplacental glioma rat model.

Authors:  Vasanth Kumar Bhaskara; Challa Sundaram; Phanithi Prakash Babu
Journal:  Neurochem Res       Date:  2006-08-31       Impact factor: 4.414

7.  PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration.

Authors:  Ganta Vijay Chaitanya; Alexander J Steven; Phanithi Prakash Babu
Journal:  Cell Commun Signal       Date:  2010-12-22       Impact factor: 5.712

8.  Anticancer activity of extracts derived from the mature roots of Scutellaria baicalensis on human malignant brain tumor cells.

Authors:  Adrienne C Scheck; Krya Perry; Nicole C Hank; W Dennis Clark
Journal:  BMC Complement Altern Med       Date:  2006-08-16       Impact factor: 3.659

9.  Effects of ERK1/2 S-nitrosylation on ERK1/2 phosphorylation and cell survival in glioma cells.

Authors:  Lei Jin; Yujia Cao; Tong Zhang; Peng Wang; Daofei Ji; Xuejiao Liu; Hengliang Shi; Lei Hua; Rutong Yu; Shangfeng Gao
Journal:  Int J Mol Med       Date:  2017-12-20       Impact factor: 4.101

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.